$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How to identify the authenticity of Bosutinib drugs
2026-02-01 22:25:32
Check Details
How long does it take for Nintedanib/Vigat to take effect? u200bu200bPatients need to be mentally prepared
2026-02-01 22:25:32
Check Details
The SCALE-UP study: findings from real-world use of upadatinib/reflex in atopic dermatitis
2026-02-01 22:25:32
Check Details
What is the target of bimetinib/bemetinib?
2026-02-01 22:25:32
Check Details
Is Teclistamab available in the country?
2026-02-01 22:25:32
Check Details
Regular purchase channels for aprocitentan and instructions on how to obtain genuine drugs
2026-02-01 22:25:32
Check Details
Comparative analysis of the weight loss effects of tilpotide/tilsiparatide (Mufenda) and liraglutide
2026-02-01 22:25:32
Check Details
Efficacy and case studies of pitubrutinib/pitobrutinib (Zepali) in the treatment of lymphoma
2026-02-01 22:25:32
Check Details
Do patients with prostate cancer need long-term medication when using talazoparib (Tazena)?
2026-02-01 22:25:32
Check Details
Explanation of differences between producing countries and importing countries of Crizotinib
2026-02-01 22:25:32
Check Details
Can aprocitentan be discontinued suddenly and the possible risks caused by discontinuation
2026-02-01 22:25:32
Check Details
Precautions for use of tilpotide/tilsiparatide (Mufenda) and safety guide for daily medication
2026-02-01 22:25:32
Check Details
1
2
...
2381
2382
2383
2384
2385
2386
2387
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma